Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 25, 2010

 

 

Kewaunee Scientific Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-5286   38-0715562

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

2700 West Front Street

Statesville, NC 28677

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

On August 25, 2010, the Company held its 2010 Annual Meeting of Stockholders. At that meeting, the Company’s shareholders voted on the matters set forth below.

1. Each of the nominees named below was re-elected as a Class III director for a three year term as follows:

 

Name of Nominee

   For    Withheld    Broker Non-Votes

Ross W. McCanless

   1,673,879    17,326    834,245

Patrick L. McCrory

   1,671,426    19,779    834,245

Margaret B. Pyle

   1,674,331    16,874    834,245

2. The shareholders approved the 2010 Stock Option Plan for Directors as follows:

 

For

   Against    Abstained    Broker Non-Votes

1,512,159

   174,815    4,231    834,245

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
Number
  

Description

10.1    2010 Stock Option Plan for Directors (incorporated by reference to Appendix A to the Company’s Proxy Statement dated July 23, 2010 for its Annual Meeting of Stockholders on August 25, 2010).
10.2    Form of Stock Option Certificate under the Company’s 2010 Stock Option Plan for Directors.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 27, 2010

 

Kewaunee Scientific Corporation
By:  

/s/ D. Michael Parker

  D. Michael Parker
 

Senior Vice President, Finance and

Chief Financial Officer